A Novel Role of Prolidase in Cocaine-Mediated Breach in the Barrier of Brain Microvascular Endothelial Cells.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
22 02 2019
Historique:
received: 12 06 2018
accepted: 26 11 2018
entrez: 24 2 2019
pubmed: 24 2 2019
medline: 12 9 2020
Statut: epublish

Résumé

Cocaine use is associated with breach in the blood brain barrier (BBB) and increased HIV-1 neuro-invasion. We show that the cellular enzyme "Prolidase" plays a key role in cocaine-induced disruption of the BBB. We established a barrier model to mimic the BBB by culturing human brain microvascular endothelial cells (HBMECs) in transwell inserts. In this model, cocaine treatment enhanced permeability of FITC-dextran suggesting a breach in the barrier. Interestingly, cocaine treatment increased the activity of matrix metallo-proteinases that initiate degradation of the BBB-associated collagen. Cocaine exposure also induced prolidase expression and activity in HBMECs. Prolidase catalyzes the final and rate-limiting step of collagen degradation during BBB remodeling. Knock-down of prolidase abrogated cocaine-mediated increased permeability suggesting a direct role of prolidase in BBB breach. To decipher the mechanism by which cocaine regulates prolidase, we probed the inducible nitric oxide synthase (iNOS) mediated phosphorylation of prolidase since mRNA levels of the protein were not altered upon cocaine treatment. We observed increased iNOS expression concurrent with increased prolidase phosphorylation in cocaine treated cells. Subsequently, inhibition of iNOS decreased prolidase phosphorylation and reduced cocaine-mediated permeability. Finally, cocaine treatment increased transmigration of monocytic cells through the HBMEC barrier. Knock-down of prolidase reduced cocaine-mediated monocyte transmigration, establishing a key role of prolidase in cocaine-induced breach in endothelial cell barrier.

Identifiants

pubmed: 30796241
doi: 10.1038/s41598-018-37495-6
pii: 10.1038/s41598-018-37495-6
pmc: PMC6385491
doi:

Substances chimiques

NOS2 protein, human EC 1.14.13.39
Nitric Oxide Synthase Type II EC 1.14.13.39
Dipeptidases EC 3.4.13.-
PEPD protein, human EC 3.4.13.9
Cocaine I5Y540LHVR

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2567

Subventions

Organisme : NIMHD NIH HHS
ID : U54 MD007586
Pays : United States
Organisme : NIDA NIH HHS
ID : R24 DA036420
Pays : United States
Organisme : NIDA NIH HHS
ID : R03 DA030896
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007281
Pays : United States
Organisme : NIGMS NIH HHS
ID : R25 GM059994
Pays : United States
Organisme : NCRR NIH HHS
ID : UL1 RR024975
Pays : United States
Organisme : NIDA NIH HHS
ID : R00 DA024558
Pays : United States
Organisme : NIDA NIH HHS
ID : K99 DA024558
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI136740
Pays : United States
Organisme : NIMHD NIH HHS
ID : G12 MD007586
Pays : United States
Organisme : NIDA NIH HHS
ID : R24 DA021471
Pays : United States
Organisme : NIAID NIH HHS
ID : R56 AI122960
Pays : United States
Organisme : NIDA NIH HHS
ID : R03 DA033892
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI110527
Pays : United States
Organisme : NIMHD NIH HHS
ID : U54 MD007593
Pays : United States
Organisme : NCRR NIH HHS
ID : U54 RR026140
Pays : United States
Organisme : NIDA NIH HHS
ID : R03 DA037779
Pays : United States

Références

J Neurovirol. 1998 Dec;4(6):619-26
pubmed: 10065903
Mol Neurobiol. 1999 Jun;19(3):267-84
pubmed: 10495107
Am J Pathol. 1999 Nov;155(5):1599-611
pubmed: 10550317
J Neurovirol. 1999 Dec;5(6):579-90
pubmed: 10602399
Clin Diagn Lab Immunol. 2000 Jan;7(1):96-100
pubmed: 10618285
Life Sci. 2000 May 5;66(24):2357-69
pubmed: 10864098
Clin Infect Dis. 2000 Jul;31(1):80-4
pubmed: 10913401
Am J Emerg Med. 2000 Sep;18(5):593-8
pubmed: 10999576
Nitric Oxide. 2001 Feb;5(1):62-71
pubmed: 11178938
Nature. 2001 Apr 19;410(6831):988-94
pubmed: 11309629
J Infect Dis. 2001 Jun 15;183(12):1749-59
pubmed: 11372027
J Neurovirol. 2001 Feb;7(1):66-71
pubmed: 11519485
Eur J Vasc Endovasc Surg. 2002 Mar;23(3):260-9
pubmed: 11914015
Clin Exp Immunol. 2002 May;128(2):245-54
pubmed: 11985514
J Infect Dis. 2002 Dec 1;186 Suppl 2:S193-8
pubmed: 12424697
Stroke. 2003 Aug;34(8):2025-30
pubmed: 12855824
Adv Drug Deliv Rev. 2003 Nov 28;55(12):1531-46
pubmed: 14623400
Stroke. 2004 Apr;35(4):998-1004
pubmed: 15001799
Neurosci Lett. 2004 Feb 19;356(3):183-6
pubmed: 15036625
Neurobiol Dis. 2004 Jun;16(1):1-13
pubmed: 15207256
J Neuroimmunol. 2004 Dec;157(1-2):56-60
pubmed: 15579280
Psychiatry Res. 1992 Feb;41(2):163-77
pubmed: 1574543
J Neurovirol. 2005 Jul;11(3):281-91
pubmed: 16036808
Trends Pharmacol Sci. 1992 May;13(5):193-200
pubmed: 1604712
J Cell Biochem. 2005 Dec 1;96(5):1086-94
pubmed: 16167338
Ciba Found Symp. 1992;166:81-9; discussion 89-95
pubmed: 1638923
Nat Med. 2006 Apr;12(4):441-5
pubmed: 16565723
Neuropathol Appl Neurobiol. 2006 Jun;32(3):304-17
pubmed: 16640649
Stroke. 2006 Jun;37(6):1399-406
pubmed: 16690896
Learn Mem. 2007 Mar 09;14(3):214-23
pubmed: 17353546
Int J Cancer. 2008 Mar 15;122(6):1435-40
pubmed: 17999410
J Neuroimmune Pharmacol. 2008 Mar;3(1):52-6
pubmed: 18046654
Curr Opin Pharmacol. 2008 Feb;8(1):82-9
pubmed: 18226583
Amino Acids. 2008 Nov;35(4):731-8
pubmed: 18320291
Amino Acids. 2008 Nov;35(4):739-52
pubmed: 18340504
Neurosci Biobehav Rev. 2008 Jul;32(5):883-909
pubmed: 18430470
Synapse. 2008 Sep;62(9):710-3
pubmed: 18566976
J Nutr. 2008 Oct;138(10):2008S-2015S
pubmed: 18806116
Methods Mol Biol. 2009;485:41-53
pubmed: 19020817
AIDS Patient Care STDS. 2008 Nov;22(11):869-77
pubmed: 19025481
J Neurochem. 2009 Feb;108(3):811-20
pubmed: 19187098
J Neurovirol. 2009 Apr;15(2):111-22
pubmed: 19306229
Neuropsychol Rev. 2009 Jun;19(2):152-68
pubmed: 19462243
Curr Neuropharmacol. 2008 Sep;6(3):179-92
pubmed: 19506719
Open Pharmacol J. 2008;2(9):70-78
pubmed: 19568322
Curr Drug Abuse Rev. 2009 May;2(2):143-56
pubmed: 19630745
Cell Microbiol. 2010 Jan;12(1):67-83
pubmed: 19732056
Int Rev Neurobiol. 2009;88:297-334
pubmed: 19897082
Liver Int. 2010 Sep;30(8):1198-210
pubmed: 20492508
Ann Neurol. 2010 Jun;67(6):699-714
pubmed: 20517932
Amino Acids. 2011 Jul;41(2):271-90
pubmed: 20640864
J Affect Disord. 2011 Mar;129(1-3):84-6
pubmed: 20888649
Blood. 2011 Feb 24;117(8):2538-47
pubmed: 21148086
Dev Neurobiol. 2011 Nov;71(11):1018-39
pubmed: 21780303
J Neurochem. 2012 Jan;120(1):147-56
pubmed: 22007835
Neurotox Res. 2013 Feb;23(2):174-88
pubmed: 22714667
Front Pharmacol. 2012 Jun 29;3:121
pubmed: 22754527
Forensic Sci Int. 1990 Dec;48(2):135-8
pubmed: 2283136
PLoS One. 2012;7(12):e51387
pubmed: 23251514
J Neuroimmune Pharmacol. 2013 Jun;8(3):621-42
pubmed: 23456305
Neurol Sci. 2013 Dec;34(12):2117-21
pubmed: 23479033
J Clin Exp Neuropsychol. 2013;35(4):421-34
pubmed: 23547924
Nature. 1986 Jul 10-16;322(6075):130-6
pubmed: 2425264
Fluids Barriers CNS. 2013 Nov 22;10(1):33
pubmed: 24262108
AIDS Res Ther. 2014 May 19;11:13
pubmed: 24894206
J Neuroimmune Pharmacol. 2014 Dec;9(5):703-15
pubmed: 25209871
Nat Neurosci. 2014 Dec;17(12):1655-7
pubmed: 25326689
Mol Biol Rep. 2015 Jan;42(1):1-11
pubmed: 25374425
J Pak Med Assoc. 2015 Feb;65(2):131-5
pubmed: 25842545
J Mol Psychiatry. 2014 Mar 04;2(1):2
pubmed: 25945248
Front Mol Biosci. 2015 May 13;2:19
pubmed: 25988186
Parkinsons Dis. 2015;2015:598028
pubmed: 26347150
Biol Trace Elem Res. 2016 May;171(1):48-53
pubmed: 26364956
J Pharmacol Sci. 2015 Oct;129(2):83-94
pubmed: 26499181
Front Microbiol. 2015 Oct 20;6:1111
pubmed: 26539167
Adv Drug Deliv Rev. 2016 Feb 1;97:4-27
pubmed: 26562801
Neurosci Lett. 2016 Feb 2;613:36-40
pubmed: 26724223
FEBS J. 2017 Sep;284(17):2870-2885
pubmed: 28677335
Virology. 1985 Nov;147(1):231-6
pubmed: 2998068
Science. 1976 Feb 27;191(4229):859-61
pubmed: 56036
Cancer Res. 1981 Nov;41(11 Pt 1):4629-36
pubmed: 6458354
JAMA. 1984 Oct 12;252(14):1889-93
pubmed: 6471319
Ann N Y Acad Sci. 1994 Sep 6;732:315-23
pubmed: 7978801
J Psychoactive Drugs. 1993 Jul-Sep;25(3):207-21
pubmed: 8258759
AIDS. 1996 Apr;10(4):431-40
pubmed: 8728048
Adv Exp Med Biol. 1996;402:145-56
pubmed: 8787655
NIDA Res Monogr. 1996;163:43-65
pubmed: 8809853
J Dermatol. 1997 Oct;24(10):626-9
pubmed: 9375460
Acta Neuropathol. 1997 Dec;94(6):590-8
pubmed: 9444361
J Forensic Sci. 1998 Jan;43(1):41-5
pubmed: 9456523
J Virol. 1998 Apr;72(4):2855-64
pubmed: 9525605
Adv Exp Med Biol. 1998;437:199-205
pubmed: 9666272

Auteurs

Binah Baht Ysrayl (BB)

Center for AIDS Health Disparities Research, Meharry Medical College, Nashville, Tennessee, USA.
Center for Molecular and Behavioral Neurosciences, Meharry Medical College, Nashville, Tennessee, USA.
School of Graduate Studies and Research, Meharry Medical College, Nashville, Tennessee, USA.
Department of Microbiology, Immunology, and Physiology, Meharry Medical College, Nashville, Tennessee, USA.

Muthukumar Balasubramaniam (M)

Center for AIDS Health Disparities Research, Meharry Medical College, Nashville, Tennessee, USA.
Center for Molecular and Behavioral Neurosciences, Meharry Medical College, Nashville, Tennessee, USA.
Department of Microbiology, Immunology, and Physiology, Meharry Medical College, Nashville, Tennessee, USA.

Ife Albert (I)

Center for AIDS Health Disparities Research, Meharry Medical College, Nashville, Tennessee, USA.

Fernando Villalta (F)

Department of Microbiology, Immunology, and Physiology, Meharry Medical College, Nashville, Tennessee, USA.

Jui Pandhare (J)

Center for AIDS Health Disparities Research, Meharry Medical College, Nashville, Tennessee, USA. jpandhare@mmc.edu.
Center for Molecular and Behavioral Neurosciences, Meharry Medical College, Nashville, Tennessee, USA. jpandhare@mmc.edu.
School of Graduate Studies and Research, Meharry Medical College, Nashville, Tennessee, USA. jpandhare@mmc.edu.
Department of Microbiology, Immunology, and Physiology, Meharry Medical College, Nashville, Tennessee, USA. jpandhare@mmc.edu.

Chandravanu Dash (C)

Center for AIDS Health Disparities Research, Meharry Medical College, Nashville, Tennessee, USA. cdash@mmc.edu.
Center for Molecular and Behavioral Neurosciences, Meharry Medical College, Nashville, Tennessee, USA. cdash@mmc.edu.
School of Graduate Studies and Research, Meharry Medical College, Nashville, Tennessee, USA. cdash@mmc.edu.
Department of Microbiology, Immunology, and Physiology, Meharry Medical College, Nashville, Tennessee, USA. cdash@mmc.edu.
Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College, Nashville, Tennessee, USA. cdash@mmc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH